New nerve pain drug passes first safety test in humans
NCT ID NCT07586514
First seen May 15, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This early-stage study tested a single dose of the experimental drug 4ET1103 in 40 healthy adults to see if it is safe and how the body processes it. Half received the drug, half a placebo, and all were monitored for side effects and changes in blood, urine, and vital signs. The goal is to develop a new treatment for neuropathic pain, a type of chronic pain from nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PPD
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.